Pulmonx (LUNG) Other financing activities (2019 - 2025)

Pulmonx (LUNG) has reported Other financing activities for 7 consecutive years, with $5000.0 the latest figure, recorded in Q3 2025.

• On a quarterly basis, Other financing activities fell 82.14% year-over-year to $5000.0 in Q3 2025; TTM through Sep 2025 was $253000.0, a 47.09% increase from a year earlier, with the FY2024 full-year figure at $218000.0, down 29.68% from the prior year.
• Other financing activities was $5000.0 for Q3 2025 at Pulmonx, down from $28000.0 in the prior quarter.
• Over five years, Other financing activities peaked at $1.3 million in Q2 2021 and troughed at $5000.0 in Q3 2025.
• A 5-year average of $167684.2 and a median of $72000.0 in 2022 frame the typical range for Other financing activities.
• Across the five-year window, Other financing activities plunged 99.92% in 2021 and soared 200.0% in 2022, its largest moves.
• Over 5 years, Other financing activities stood at $150000.0 in 2021, then climbed by 26.67% to $190000.0 in 2022, then slumped by 66.32% to $64000.0 in 2023, then surged by 71.88% to $110000.0 in 2024, then plunged by 95.45% to $5000.0 in 2025.
• The last three Other financing activities figures came in at $5000.0 (Q3 2025), $28000.0 (Q2 2025), and $110000.0 (Q1 2025), per Business Quant data.